1. Academic Validation
  2. Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells

Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells

  • Cancer Res. 2009 Jan 1;69(1):75-83. doi: 10.1158/0008-5472.CAN-08-1393.
Bin Zhang 1 Yun Xiu Bai Hang Hang Ma Feng Feng Rui Jin Zhi Long Wang Jian Lin Shi Peng Sun Pingxun Yang Xiao Xiong Wang Pei Tang Huang Cui Fen Huang Ying Peng Yang Chao Chen Hsiang-Fu Kung Jun Jian Huang
Affiliations

Affiliation

  • 1 Laboratory of Tumor and Molecular Biology, Beijing Institute of Biotechnology, Department of Urology, General Hospital of People's Liberation Army, Beijing, P.R. China.
Abstract

The nucleolar protein PinX1 has been proposed to be a putative tumor suppressor due to its binding to and inhibition of the catalytic activity of Telomerase, an Enzyme that is highly expressed in most human cancers in which it counteracts telomere shortening-induced senescence to confer Cancer cell immortalization. However, the role of PinX1 in telomere regulation, as well as in Cancer, is still poorly understood. In this study, we showed that the PinX1 protein is constitutively expressed in various human cells regardless of their Telomerase activity and malignant status. Most interestingly, we found that silencing PinX1 expression by a potent short hairpin RNA construct led to a robust telomere length shortening and growth inhibition in telomerase-positive but not in telomerase-negative human Cancer cells. We further showed that silencing PinX1 significantly reduced the endogenous association of Telomerase with the Pot1-containing telomeric protein complex, and therefore, could account for the phenotypic telomere shortening in the affected telomerase-positive Cancer cells. Our results thus reveal a novel positive role for PinX1 in Telomerase/telomere regulations and suggest that the constitutive expression of PinX1 attributes to telomere maintenance by Telomerase and tumorigenicity in Cancer cells.

Figures